The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)

Mikkael A. Sekeres*, Arlene S. Swern, Aristoteles Giagounidis, Alan F. List, Dominik Selleslag, Moshe Mittelman, Brigitte Schlegelberger, Gudrun Göhring, Jack Shiansong Li, Mary M. Sugrue, Pierre Fenaux

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number90
JournalBlood Cancer Journal
Issue number10
StatePublished - 1 Oct 2018

Cite this